Share “Pfizer: Long-acting Lyrica better than...”

Pfizer: Long-acting Lyrica better than placebo

Associated Press Modified: November 19, 2012 at 4:00 pm •  Published: November 19, 2012

Lyrica sales have been growing steadily, hitting $1.04 billion in the third quarter. It's Pfizer's top-selling drug, since megablockbuster Lipitor for high cholesterol got generic competition last Nov. 30.

Possible side effects from Lyrica include dizziness, sleepiness, blurred vision, weight gain, increased appetite, trouble concentrating, rapid swelling of the skin's deeper layers, euphoric mood and balance disorder.